The medical technology company Getinge delivers a so-called report smoker that stands out in the flow of quarterly reports from the stock exchange companies.
The share rises by almost 8 percent on the Stockholm Stock Exchange in the initial trading after the report.
For the second quarter of the year, the profit increases significantly above the average forecast among analysts. Sales and order intake also rise more than expected.
The adjusted operating profit for the quarter more than doubles to 922 million kronor, up from 442 million kronor during the second quarter last year.
Strong sales and product mix are behind the profit increase, according to CEO Mattias Perjos.
Net sales rise to 8.3 billion kronor, up from 7.2 billion, while order intake increases to 8.4 billion from 7.4 billion.
With the price increase, the Getinge share's price fall since the turn of the year is reduced to around 10 percent.
